These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4016042)

  • 1. Medical conditions underlying recurrence of retinal vein occlusion.
    Dodson PM; Kubicki AJ; Taylor KG; Kritzinger EE
    Br J Ophthalmol; 1985 Jul; 69(7):493-6. PubMed ID: 4016042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
    Dodson PM; Galton DJ; Hamilton AM; Blach RK
    Br J Ophthalmol; 1982 Mar; 66(3):161-4. PubMed ID: 7066266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion.
    Dodson PM; Kritzinger EE
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():114-9. PubMed ID: 3857768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension.
    Cole MD; Dodson PM; Hendeles S
    Br J Ophthalmol; 1989 Sep; 73(9):693-8. PubMed ID: 2804022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion.
    Dodson PM; Westwick J; Marks G; Kakkar VV; Galton DJ
    Br J Ophthalmol; 1983 Mar; 67(3):143-6. PubMed ID: 6186271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal vein occlusion: C-reactive protein and arterial hypertension.
    Dodson PM; Shine B
    Acta Ophthalmol (Copenh); 1984 Feb; 62(1):123-30. PubMed ID: 6720266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for branch retinal vein occlusion. The Eye Disease Case-control Study Group.
    Am J Ophthalmol; 1993 Sep; 116(3):286-96. PubMed ID: 8357052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal vascular abnormalities in the hyperlipidaemias.
    Dodson PM; Galton DJ; Winder AF
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):17-21. PubMed ID: 6964227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bilateral retinal vein occlusions and general risk factors].
    Darrelmann O; Kreissig I; Richard G
    Klin Monbl Augenheilkd; 1985 Jan; 186(1):39-42. PubMed ID: 3974159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure in retinal vein occlusion.
    Frucht J; Shapiro A; Merin S
    Br J Ophthalmol; 1984 Jan; 68(1):26-8. PubMed ID: 6689932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of lipid changes in rhegmatogenous retinal detachment, retinal vein occlusion and primary chronic glaucoma].
    Weiser M; Serog P; Apfelbaum M; Rousselie F
    J Fr Ophtalmol; 1985; 8(10):619-22. PubMed ID: 3833877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal vein occlusion and lipoprotein (a)].
    Ribeaudeau-Saindelle F; Glacet-Bernard A; Lelong F; Coscas G; Soubrane G
    J Fr Ophtalmol; 1998 Apr; 21(4):245-50. PubMed ID: 9759412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there medical conditions specifically underlying the development of rubeosis in central retinal vein occlusion?
    Keenan JM; Dodson PM; Kritzinger EE
    Eye (Lond); 1993; 7 ( Pt 3)():407-10. PubMed ID: 7693518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral retinal branch vein occlusion.
    Mandel ER; Schwartz PL; Rosen DA
    Ann Ophthalmol; 1982 Apr; 14(4):387, 390-1. PubMed ID: 7103324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinaemia: risk of retinal vascular occlusion.
    Yaghoubi GH; Madarshahian F; Mosavi M
    East Mediterr Health J; 2004; 10(4-5):633-9. PubMed ID: 16335656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Telemedical-supported screening of retinal vessels ("talking eyes")].
    Michelson G; Groh M; Groh MJ; Baleanu D; Harazny J; Horstmann R; Kolominsky-Rabas P
    Klin Monbl Augenheilkd; 2005 Apr; 222(4):319-25. PubMed ID: 15844042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies.
    Wong TY; Larsen EK; Klein R; Mitchell P; Couper DJ; Klein BE; Hubbard LD; Siscovick DS; Sharrett AR
    Ophthalmology; 2005 Apr; 112(4):540-7. PubMed ID: 15808241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular changes after retinal branch vein occlusion.
    Shilling JS
    Trans Ophthalmol Soc U K (1962); 1976 Jul; 96(2):193-6. PubMed ID: 1070869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.